Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients are associated with significantly higher clearance

被引：0
|
作者：
Militano, O
Roache, K
Shaw, LM
Figurski, M
Satwani, P
Ayello, J
Wolownik, K
Foley, S
Hawkes, R
Del Toro, G
Bradley, MB
George, D
Garvin, J
Bhatia, M
Roman, L
Cairo, MS
机构：
[1] New York Presbyterian, New York, NY USA
[2] Columbia Univ, New York, NY USA
[3] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1823
引用
收藏
页码：518A / 518A
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O.
    Hedgpeth, D.
    Shaw, L. M.
    Figurski, M.
    Satwani, P.
    Ayello, J.
    Roman, E.
    Bradley, B.
    George, D.
    Garvn, J.
    Bhatia, M.
    Wolownick, K.
    Foley, S.
    Hawkes, R.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 114 - 115
  • [2] Higher clearance rates of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O
    Roache, K
    Shaw, LM
    Figurski, M
    Satwani, P
    Ayello, J
    Roman, E
    Del Toro, G
    Bradley, B
    George, D
    Garvin, JH
    Bhatia, M
    Wolownik, K
    Foley, S
    Hawks, R
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 57 - 58
  • [3] PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) IN COMBINATION WITH TACROLIMUS IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS ≤ 12 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Figurski, M.
    Shaw, L.
    Geyer, M. B.
    Jacobson, J. S.
    Morris, F.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S191 - S191
  • [4] PHARMACOKINETICS (PK) OF IV AND PO MYCOPHENOLATE MOFETIL (MMF) IN AGE ADJUSTED PEDIATRIC AND ADOLESCENT ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS: SIGNIFICANTLY HIGHER CLss AND Vss IN PATIENTS <6 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Jin, Z.
    Figurski, M.
    Shaw, L.
    Moore, V
    Morris, E.
    Tallamy, B.
    van de Ven, C.
    Ayello, J.
    Baxter-Lowe, L. A.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 132 - 133
  • [5] Significant alterations of mycophenolate mofetil (MMF) pharmacokinetics in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Alternate dosing is required in AlloSCT compared to solid organ autograft recipients.
    Bessmertny, O
    Harrison, L
    Osunkwo, I
    Wischhover, C
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Cairo, MS
    BLOOD, 2002, 100 (11) : 418A - 419A
  • [6] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Cheung, YK
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 103 - 103
  • [7] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD.
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Skerrett, D
    Cairo, MS
    BLOOD, 2003, 102 (11) : 713A - 713A
  • [8] Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Garvin, J
    George, D
    Bradley, MB
    DelToro, G
    Wischhover, C
    Wolownik, K
    van de Ven, C
    Cheung, YK
    Cairo, MS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 528A - 528A
  • [9] Pharmacokinetics of Mycophenolate Mofetil in Pediatric Liver Transplant Recipients to Optimize MMF Dose
    Barau, C.
    Habes, D.
    Debray, D.
    Taburet, A. M.
    Furlan, V.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 651 - 652
  • [10] Pharmacokinetics of mycophenolate mofetil in stem cell transplant recipients
    van Hest, Reimer M.
    Doorduijn, Jeanette K.
    de Winter, Brenda C. M.
    Comelissen, Jan J.
    Vulto, Arnold G.
    Oellerich, Michael
    Lowenberg, Bob
    van Gelder, Teun
    Armstrong, Victor W.
    Mathot, Ron A. A.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 471 - 471
12345